Working groups

Discussions have been going on behind the scenes as to the best way to formulate working groups, to ensure the detail is not lost in the plethora of ATMP modalities and the groups can be convened and run sustainably.  The status of the working groups is as below.

  • Patient access – Åse Rosenqvist, Björn Skölving, Fredrik Jerhammar, Astrid Wirén, Kinga Täckström, Peter Carlqvist, Peter Hertzman. Suggested additions: Mikael Svensson and IHE.
    • HE models suitable for ATMP modalities
    • Payment models suitable for ATMP HE assessments
    • Integrating education around ATMPs into existing training programs
    • Feeding information back to early stage developers
  • Patient organisation engagement – Kerstin Sollerbrant, Ahmed Elserafy, Filipe Rodrigues. Suggested additions: Oskar Ahlberg, Fredrik Östman and Mats Jerkeman.
    • Patients contributing to product development and clinical trials design
    • Access to information on therapeutic options and clinical trials
  • Women in advanced therapies – Jenny Stjernberg, Jennifer Rosendahl, Lucienne Vonk, Ila Jasra and Ewa Ellis.
    • Recognising the benefits of diversity and supporting its implementation
  • Enabling academic ATMP developments – Henrik Moller Thomsen
    • major gaps in the bench to bedside pipeline eg. researchers, developers/PD, manufacturing and treating physicians.
    • working to solve these gaps through information, education and “match making”
  • Chemistry Manufacturing and Control (CMC) – Lilian Walther Jallow, Erik Steffensen, Anna Pasetto, Zhong Yu, Ila Jasra, Anna Renglin Lindh.